New Age Alpha Advisors LLC purchased a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 74,978 shares of the company's stock, valued at approximately $6,924,000. New Age Alpha Advisors LLC owned 0.07% of Encompass Health as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Norges Bank purchased a new position in shares of Encompass Health in the fourth quarter worth about $100,637,000. Segall Bryant & Hamill LLC grew its stake in Encompass Health by 3.6% in the 4th quarter. Segall Bryant & Hamill LLC now owns 165,894 shares of the company's stock valued at $15,320,000 after buying an additional 5,757 shares in the last quarter. Prudential Financial Inc. raised its holdings in Encompass Health by 1.7% during the 4th quarter. Prudential Financial Inc. now owns 43,426 shares of the company's stock valued at $4,010,000 after acquiring an additional 735 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Encompass Health by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company's stock worth $960,817,000 after acquiring an additional 138,196 shares during the period. Finally, Stevens Capital Management LP bought a new stake in shares of Encompass Health during the 4th quarter valued at $257,000. 97.25% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several equities analysts recently commented on EHC shares. Barclays boosted their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, February 7th. KeyCorp upped their price target on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a research report on Saturday, February 15th. Royal Bank of Canada restated an "outperform" rating and issued a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. Finally, William Blair reiterated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Ten equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Buy" and an average price target of $107.67.
Get Our Latest Research Report on Encompass Health
Insider Activity at Encompass Health
In other news, CAO Andrew L. Price sold 5,042 shares of the company's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.10% of the stock is currently owned by insiders.
Encompass Health Trading Up 0.1 %
EHC traded up $0.14 during midday trading on Tuesday, reaching $101.25. 119,972 shares of the company's stock traded hands, compared to its average volume of 647,628. The stock has a market capitalization of $10.20 billion, a price-to-earnings ratio of 22.80, a P/E/G ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a 52 week low of $78.53 and a 52 week high of $104.55. The firm has a fifty day moving average of $98.81 and a two-hundred day moving average of $97.52. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04.
Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, equities analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.
Encompass Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's payout ratio is 15.25%.
About Encompass Health
(
Free Report)
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
See Also
Before you consider Encompass Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Encompass Health wasn't on the list.
While Encompass Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.
